{"id":"W4401728325","doi":"10.1097/cad.0000000000001658","title":"Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Structural Genomics Consortium","funders":"Ontario Genomics Institute; National Cancer Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Ontario Genomics; Genome Canada; McGill University; Genentech; Bayer; Tulane University; Pfizer; Bristol-Myers Squibb","keywords":"Kinome; Cyclin-dependent kinase 4; Triple-negative breast cancer; Cancer research; Kinase; Cyclin-dependent kinase; Cyclin-dependent kinase 7; Biology; Cyclin-dependent kinase 2; Cyclin-dependent kinase 9; Cancer; Cell biology; Cell cycle; Breast cancer; Protein kinase A; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002784003,0.0004497393,0.0008366695,0.0006721085,0.00008273996,0.00009617418,0.0002358135,0.000259498,0.001471031],"category_scores_gemma":[0.00004829183,0.0004348732,0.0003435707,0.001907993,0.0002039591,0.0007524453,0.0001924698,0.0007654363,0.00003433526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002939277,"about_ca_system_score_gemma":0.001269636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005879431,"about_ca_topic_score_gemma":0.0003034555,"domain_scores_codex":[0.9969115,0.00006993412,0.0008053236,0.0008882835,0.0006387719,0.000686203],"domain_scores_gemma":[0.9987627,0.0001052553,0.0002105311,0.0005242642,0.0001340453,0.0002632186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001389303,0.0007989368,0.006773929,0.002125775,0.0007783608,0.000743776,0.00470637,0.0007796144,0.9235031,0.0009780634,0.01536019,0.04206261],"study_design_scores_gemma":[0.01017586,0.0001858848,0.01932529,0.01034227,0.0005231582,0.00007848843,0.00114145,0.007420616,0.9366668,0.0001998626,0.01299336,0.000946962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9658204,0.02103944,0.0008392018,0.002631317,0.002045685,0.001515683,0.002911151,0.0003902562,0.002806871],"genre_scores_gemma":[0.9924734,0.002024448,0.001000349,0.0005781868,0.0006547998,0.0003095919,0.0001370035,0.0001758181,0.002646416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04111565,"threshold_uncertainty_score":0.9998103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01825964053707128,"score_gpt":0.2670174725904091,"score_spread":0.2487578320533378,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}